A protein found in brown fat, but not typical white fat, is key to how the energy-burning brown fat cells function
While most fat cells in the human body store energy, everyone has a small subset of brown fat cells that do the opposite—burn energy and generate heat. Now, Salk researchers have discovered how the molecule ERR? gives this “healthier” brown fat its energy-expending identity, making those cells ready to warm you up when you step into the cold, and potentially offering a new therapeutic target for diseases related to obesity. The paper appears in Cell Reports on March 13, 2018.
“This not only advances our understanding of how the body responds to cold, but could lead to new ways to control the amount of brown fat in the body, which has links to obesity, diabetes and fatty liver disease,” says senior author Ronald Evans, Howard Hughes Medical Institute investigator and holder of Salk’s March of Dimes Chair in Molecular and Developmental Biology.
Until about a decade ago, scientists thought that only babies—who can’t yet shiver to warm up—had brown fat in their bodies. Studies have since shown that adults also have brown fat, albeit at much lower levels, and people with lower body mass indexes (BMIs) tend to have more of it. At a cellular level, brown fat cells are crammed full of energy-generating mitochondria, which give the cells their brown color.
In the new work, Evans’ group focused on estrogen-related receptor gamma (ERR?), a gene that is active at high levels in brown fat cells.
“We were interested in what maintains brown fat, even when we’re not exposed to cold all the time,” says Maryam Ahmadian, a Salk research associate and first author of the new paper.
The team found that brown fat cells express the ERR? gene all the time (not just in response to cold) and that white fat cells do not express the gene at all. And by studying mice lacking the gene for ERR? (and therefore unable to make the ERRy molecule), the team observed that all brown fat cells resembled white cells in these mice. Additionally, the animals were unable to maintain their body temperature when exposed to cold temperatures. While 80 percent of normal mice are able to handle a temperature drop, all mice lacking ERR? did not tolerate the cold. However, there was no difference in the metabolism or weight of the mice. Together, the experiments reveal that ERR? is key to helping brown fat maintain its identity and its ability to respond to cold.
Since the ERR? gene codes for a protein that can travel into the cell nucleus and directly control the expression of other genes, the team also probed which genes were mediated by ERR? in brown fat cells. They pinpointed a number of genes already known to be important in brown fat, but which hadn’t been specifically linked to ERR? inthe past.
“We uncovered the factors that are both involved in protection against the cold and underpin brown fat identity,” says Michael Downes, a Salk senior scientist and co–senior author of the paper.
The group is planning future studies that look at the effect of activating ERR? in white fat cells—which they suspect could make some white fat resemble brown fat, and potentially help treat obesity and diabetes. They also want to study whether the role of ERR? in the brown fat of humans is the same as what they’ve observed in mice.
The Latest on: Drug for obesity
via Google News
The Latest on: Drug for obesity
- Could a once-abandoned obesity drug be revived in osteoporosis? on December 13, 2018 at 7:25 am
Irisin, the once much-hyped but controversial “exercise hormone” that researchers had hoped would be an effective obesity treatment, could make a comeback—this time in bone strengthening. In a study p... […]
- Anti-obesity Drugs: Global Markets, 2022 on December 7, 2018 at 2:04 pm
The "Global Anti-obesity Drugs Market 2018-2022" report has been added to ResearchAndMarkets.com's offering. The anti-obesity drugs market is projected to register a CAGR of almost 8% by 2023. […]
- Anti-Obesity Drug Target Could Burn Calories Even While the Body Rests on December 6, 2018 at 2:37 pm
They secret to the long-awaited anti-obesity pill could be buried deep on chromosome 21, where scientists believe a single gene might be preventing the body from burning up extra calories at rest. If ... […]
- Worldwide Opportunity Outlook on the Anti-obesity Drugs Market to 2022 - Key Players are Eisai, Novo Nordisk and Vivus - ResearchAndMarkets.com on December 6, 2018 at 7:21 am
DUBLIN--(BUSINESS WIRE)--The "Global Anti-obesity Drugs Market 2018-2022" report has been added to ResearchAndMarkets.com's offering. The anti-obesity drugs market is projected to register a CAGR of a... […]
- Visiongain Report Looks at Opportunities Within the $6.3bn Anti-Obesity Drugs Market on December 5, 2018 at 1:00 am
LONDON, December 5, 2018 /PRNewswire via COMTEX/ -- LONDON, December 5, 2018 /PRNewswire/ -- Global Anti-Obesity Drugs Market Forecast 2018-2028 Mechanism of Action, Innovator Drugs, Generics. Prescri... […]
- Aussie scientists working on the holy grail of weight loss on December 4, 2018 at 9:03 pm
The anti-fat drug could be available within a few years, and holds much hope for the fight against the country’s obesity and diabetes epidemics. The international research is led by Professor Damien K... […]
- Chicago adults consider drug abuse, obesity biggest problems facing city’s children, new survey shows on December 4, 2018 at 2:44 pm
Results of a survey released Monday found that Chicago adults consider drug abuse, obesity, and child abuse and neglect the biggest problems facing the city’s children. Among those surveyed, 64 percen... […]
- Gene that allows you eat as much as you want could help combat obesity on December 4, 2018 at 11:35 am
Led by Professor Damien Keating at Flinders University, the study used a huge genetic screen in rodents to identify novel genetic candidates that may cause obesity, potentially paving the way for new ... […]
- The Anti-obesity Drugs Market will register a CAGR of almost 8% by 2023 on December 3, 2018 at 3:49 pm
The research on drugs that target obesity and type 2 diabetes mellitus to gain traction in the market. The global epidemic obesity and type 2 diabetes is increasing. This demands for increasing focus ... […]
via Bing News